These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18161126)

  • 1. [Adherence to medications for treatment of osteoporosis].
    Tanaka I; Oshima H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():329-34. PubMed ID: 18161126
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone health medications: research questions versus clinical choices.
    Goldstein SR
    Menopause; 2011 Aug; 18(8):835-6. PubMed ID: 21785375
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
    Ohta H
    Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of postmenopausal osteoporosis].
    Mizunuma H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():490-4. PubMed ID: 18161154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Compliance of hormone replacement therapy in postmenopausal women in Japan].
    Hara Y; Shintani M
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():496-500. PubMed ID: 15035179
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients.
    Hiligsmann M; Rabenda V; Bruyère O; Reginster JY
    Health Policy; 2010 Jul; 96(2):170-7. PubMed ID: 20153543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoporosis and pharmaceutical care].
    Kövér K; Mészáros A
    Acta Pharm Hung; 2012; 82(2):75-9. PubMed ID: 22870780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
    Iwamoto J
    Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evidence of raloxifene on postmenopausal osteoporosis].
    Okano H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():374-80. PubMed ID: 18161135
    [No Abstract]   [Full Text] [Related]  

  • 12. Compliance with drug therapy for postmenopausal osteoporosis.
    Weycker D; Macarios D; Edelsberg J; Oster G
    Osteoporos Int; 2006; 17(11):1645-52. PubMed ID: 16862397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.
    Gold DT; Alexander IM; Ettinger MP
    Ann Pharmacother; 2006 Jun; 40(6):1143-50. PubMed ID: 16735667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with treatment for osteoporosis.
    Cooper A
    Lancet; 2006 Nov; 368(9548):1648. PubMed ID: 17098078
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination therapy for osteoporosis].
    Hagino H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():316-20. PubMed ID: 18161124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral osteoporosis: a review and its dental implications].
    Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y
    Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of SERMs on bone health. Combination therapy with raloxifene].
    Gorai I; Hori H
    Clin Calcium; 2010 Mar; 20(3):408-12. PubMed ID: 20190371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and prevention of osteoporosis in patients with decreased renal function].
    Vestergaard P; Eiken PA
    Ugeskr Laeger; 2008 Jan; 170(4):227-30. PubMed ID: 18282452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.